arginine has been researched along with Dyslipidemias in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 11 (57.89) | 24.3611 |
| 2020's | 3 (15.79) | 2.80 |
| Authors | Studies |
|---|---|
| Bomalaski, JS; DeBosch, BJ; Higgins, CB; Van Tine, BA; Zhang, Y | 1 |
| Cantin, C; Contreras-Duarte, S; Farias, M; Leiva, A | 1 |
| Baião, DDS; da Silva, DVT; Paschoalin, VMF; Trindade, LR | 1 |
| Singh, SA; Srinivasan, K; Venkatesh, R | 1 |
| Cholewka, A; Furmański, M; Owczarek, AJ; Stanek, A; Strzelczyk, JK; Wielkoszyński, T; Zalejska-Fiolka, J | 1 |
| Ercan, M; Firtina, S; Konukoglu, D | 1 |
| Atarashi, H; Kohashi, K; Kosugi, M; Kusama, Y; Morisawa, T; Nakagomi, A; Saiki, Y; Shimizu, W | 1 |
| Cai, A; Li, D; Liang, Q; Mai, W; Mai, Z; Qiu, R; Xu, R; Zeng, F; Zheng, D | 1 |
| Li, C; Li, M; Liu, J; Liu, Y; Wang, Z; Wen, J; Wen, S; Zhang, B | 1 |
| Azushima, K; Haku, S; Haruhara, K; Kanaoka, T; Kinguchi, S; Kobayashi, R; Ohki, K; Ohsawa, M; Tamura, K; Toya, Y; Umemura, S; Uneda, K; Wakui, H | 1 |
| Adachi, H; Fujiwara, N; Kawagoe, Y; Nakamura, T; Okuda, S; Sato, E; Suzuki, T; Ueda, S; Ueda, Y; Yamagishi, S | 1 |
| Adachi, H; Fujiwara, N; Fukami, K; Kawagoe, Y; Matsui, T; Nakamura, T; Okuda, S; Sato, E; Suzuki, T; Takeuchi, M; Ueda, S; Ueda, Y; Yamada, S; Yamagishi, S | 1 |
| Fujiwara, N; Fukami, K; Kawagoe, Y; Nakamura, T; Okuda, S; Sato, E; Suzuki, T; Ueda, S; Ueda, Y; Yamagishi, S | 1 |
| Abe, A; Katayama, Y; Katsura, K; Nagayama, H; Nishiyama, Y; Otsuka, T; Ueda, M | 1 |
| Korish, AA | 1 |
| Hashizume, K; Ichikawa, K; Kikuchi, N; Matsuzawa, A; Miyamoto, T; Nagano, R; Nakamura, T; Ohnota, H; Ozawa, T; Shiohara, H | 1 |
| Corti, R; Flammer, A; Hermann, F; Lüscher, TF; Noll, G; Spieker, LE; Sudano, I | 1 |
| Biberoğlu, G; Bideci, A; Camurdan, MO; Cinaz, P; Demirel, F; Hasanoğlu, A; Yesilkaya, E | 1 |
| Lipman, ML; Mann, JF; Schiffrin, EL | 1 |
3 review(s) available for arginine and Dyslipidemias
| Article | Year |
|---|---|
Increasing the Power of Polyphenols through Nanoencapsulation for Adjuvant Therapy against Cardiovascular Diseases.
Topics: Antioxidant Response Elements; Antioxidants; Arginine; Cardiotonic Agents; Diabetes Mellitus; Drug Carriers; Drug Compounding; Dyslipidemias; Gene Expression Regulation; Humans; Hypertension; Myocardial Ischemia; Nanocapsules; NF-E2-Related Factor 2; Nitric Oxide; Oxidative Stress; Polyphenols; Signal Transduction | 2021 |
Protection of endothelial function: targets for nutritional and pharmacological interventions.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine; Atherosclerosis; Biopterins; Cacao; Calcium Channel Blockers; Cyclooxygenase Inhibitors; Dyslipidemias; Endothelin-1; Endothelins; Endothelium, Vascular; Flavonoids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins, HDL; Nitric Oxide; Oxidative Stress; Reactive Oxygen Species | 2006 |
Chronic kidney disease: effects on the cardiovascular system.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Atherosclerosis; Biomarkers; Bone Resorption; Calcinosis; Calcium; Cardiovascular Diseases; Chronic Disease; Clinical Trials as Topic; Cohort Studies; Creatinine; Cystatin C; Cystatins; Diabetes Complications; Disease Progression; Dogs; Dyslipidemias; Endothelium, Vascular; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inflammation Mediators; Kidney Diseases; Oxidative Stress; Phosphates; Renin-Angiotensin System; Risk Factors | 2007 |
2 trial(s) available for arginine and Dyslipidemias
| Article | Year |
|---|---|
Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia.
Topics: Aged; Albuminuria; Anticholesteremic Agents; Arginine; Cholesterol, HDL; Cholesterol, LDL; Diet; Dyslipidemias; Female; Glomerular Filtration Rate; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Oxidative Stress; Quinolines; Renal Insufficiency, Chronic; Triglycerides; Vascular Stiffness | 2015 |
Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Anticholesteremic Agents; Arginine; Azetidines; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Deoxyguanosine; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fatty Acid-Binding Proteins; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Diseases; Male; Middle Aged; Proteinuria; Quinolines; Severity of Illness Index; Treatment Outcome; Triglycerides | 2010 |
14 other study(ies) available for arginine and Dyslipidemias
| Article | Year |
|---|---|
Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism.
Topics: Animals; Arginine; Autophagy; Beclin-1; Dependovirus; Diabetes Mellitus, Experimental; Diet, Western; Dyslipidemias; Energy Metabolism; Fatty Liver; Fibroblast Growth Factors; Glucose; Hepatocytes; Homeostasis; Hydrolases; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Polyethylene Glycols; Thermogenesis | 2022 |
High total cholesterol and triglycerides levels increase arginases metabolism, impairing nitric oxide signaling and worsening fetoplacental endothelial dysfunction in gestational diabetes mellitus pregnancies.
Topics: Adult; Arginase; Arginine; Cationic Amino Acid Transporter 1; Cholesterol; Diabetes, Gestational; Dyslipidemias; Endothelium; Female; Fetal Development; Fetus; Humans; Ion Transport; Nitric Oxide; Nitric Oxide Synthase Type III; Placental Function Tests; Pregnancy; Signal Transduction; Triglycerides | 2021 |
Effect of arginine:lysine and glycine:methionine intake ratios on dyslipidemia and selected biomarkers implicated in cardiovascular disease: A study with hypercholesterolemic rats.
Topics: Administration, Oral; Amino Acids; Animals; Arginine; Biomarkers; Body Weight; Cardiovascular Diseases; Dyslipidemias; Glycine; Homocysteine; Hypercholesterolemia; Lipids; Liver; Lysine; Male; Methionine; Nitric Oxide; Organ Size; Rats, Wistar | 2017 |
Oxysterols Increase Inflammation, Lipid Marker Levels and Reflect Accelerated Endothelial Dysfunction in Experimental Animals.
Topics: Animals; Arginine; Aryldialkylphosphatase; C-Reactive Protein; Cholesterol; Dyslipidemias; Homocysteine; Hypercholesterolemia; Inflammation; Interleukin-6; Lipids; Male; Oxysterols; Rabbits; Tumor Necrosis Factor-alpha | 2018 |
Comparison of plasma viscosity as a marker of endothelial dysfunction with nitric oxide and asymmetric dimethylarginine in subjects with dyslipidemia.
Topics: Adult; Aged; Arginine; Atherosclerosis; Biomarkers; Blood Viscosity; Dyslipidemias; Endothelium, Vascular; Female; Humans; Lipoproteins, LDL; Male; Middle Aged; Nitric Oxide | 2014 |
Effects of eicosapentaenoic acid on the levels of inflammatory markers, cardiac function and long-term prognosis in chronic heart failure patients with dyslipidemia.
Topics: Aged; Arginine; Biomarkers; Chemokine CCL2; Chromatography, High Pressure Liquid; Chronic Disease; Dyslipidemias; Eicosapentaenoic Acid; Female; Follow-Up Studies; Heart Failure; Humans; Inflammation Mediators; Male; Prognosis; Survival Rate; Ventricular Function, Left | 2014 |
Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats.
Topics: Animals; Arginine; Atorvastatin; Blood Glucose; Cholesterol; Cholesterol, HDL; Creatine Kinase; Dyslipidemias; Endothelium, Vascular; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardium; Nitric Oxide; Rats; Rats, Sprague-Dawley; Triglycerides | 2015 |
[Study on relationship between Trp64Arg polymorphism of β3-adrenergic receptor gene and obesity and blood lipids].
Topics: Alleles; Arginine; Blood Glucose; Body Mass Index; Dyslipidemias; Genotype; Humans; Lipids; Obesity; Polymorphism, Genetic; Receptors, Adrenergic, beta-3; Tryptophan | 2015 |
Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner.
Topics: Adult; Arginine; Azetidines; Cholesterol; Dyslipidemias; Ezetimibe; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged | 2009 |
Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.
Topics: Adult; Arginine; Cross-Sectional Studies; Dyslipidemias; Female; Glycation End Products, Advanced; Hemodynamics; HMGB1 Protein; Humans; Kidney Failure, Chronic; Male; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Regression Analysis | 2009 |
Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke.
Topics: Age Factors; Aged; Arginine; Biomarkers; Blood Glucose; Brain Ischemia; Cholesterol, LDL; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Nitric Oxide; Predictive Value of Tests; Risk Factors; Sensitivity and Specificity; Stroke; Up-Regulation | 2010 |
Multiple antioxidants and L-arginine modulate inflammation and dyslipidemia in chronic renal failure rats.
Topics: Analysis of Variance; Animals; Antioxidants; Arginine; Cytokines; Dyslipidemias; Enzyme-Linked Immunosorbent Assay; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Kidney Failure, Chronic; Kidney Function Tests; Male; Nitric Oxide; Rats; Rats, Wistar | 2010 |
Discovery of novel indane derivatives as liver-selective thyroid hormone receptor β (TRβ) agonists for the treatment of dyslipidemia.
Topics: Animals; Arginine; Cholesterol; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Dyslipidemias; Humans; Indans; Ligands; Liver; Male; Malonates; Models, Molecular; Molecular Mimicry; Molecular Structure; Rats; Rats, Wistar; Small Molecule Libraries; Structure-Activity Relationship; Thyroid Hormone Receptors beta | 2012 |
Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
Topics: Adolescent; Apolipoproteins B; Arginine; Biomarkers; Case-Control Studies; Cholesterol; Cholesterol, LDL; Dyslipidemias; Female; Humans; Leptin; Lipoprotein(a); Lipoproteins, LDL; Lipoproteins, VLDL; Multivariate Analysis; Obesity; Polycystic Ovary Syndrome; Triglycerides | 2007 |